Selected topics in myasthenia gravis / / edited by Isam Jaber Al-Zwaini, Ali Al-Mayahi.
Myasthenia gravis is a rare potentially fatal chronic autoimmune disorder. Circulating autoantibodies directed against components of the neuromuscular junction of skeletal muscles, most commonly nicotinic acetylcholine receptor and associated protein in the postsynaptic membrane, block neuromuscular...
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | London, England : : IntechOpen,, [2019] ©2019 |
Year of Publication: | 2019 |
Language: | English |
Physical Description: | 1 online resource (94 pages) :; illustrations |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993541057304498 |
---|---|
ctrlnum |
(CKB)4100000008878082 (NjHacI)994100000008878082 (oapen)https://directory.doabooks.org/handle/20.500.12854/59167 (EXLCZ)994100000008878082 |
collection |
bib_alma |
record_format |
marc |
spelling |
Ali AL-Mayahi auth Selected topics in myasthenia gravis / edited by Isam Jaber Al-Zwaini, Ali Al-Mayahi. IntechOpen 2019 London, England : IntechOpen, [2019] ©2019 1 online resource (94 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on: online resource; title from PDF information screen (InTech, viewed October 15, 2022). Includes bibliographical references. Myasthenia gravis is a rare potentially fatal chronic autoimmune disorder. Circulating autoantibodies directed against components of the neuromuscular junction of skeletal muscles, most commonly nicotinic acetylcholine receptor and associated protein in the postsynaptic membrane, block neuromuscular transmission resulting in muscle weakness. This muscle weakness typically worsens with continued activity, improves on rest, and is of variable severity ranging from mild ocular muscle weakness to severe generalized muscle weakness, involving the respiratory muscle with impending respiratory failure. The worldwide prevalence of myasthenia gravis is 100-200 per million population, affecting more than 700,000 people all over the world. The prevalence rate has increased since the 1950s due to improved diagnostic precision and decreased mortality rate. English Myasthenia gravis Diagnosis. Medicine Neurology Mental and Behavioural Disorders and Diseases of the Nervous System Health Sciences 1-83880-829-9 Al-Zwaini, Isam Jaber, editor. Al-Mayahi, Ali, editor. |
language |
English |
format |
eBook |
author |
Ali AL-Mayahi |
spellingShingle |
Ali AL-Mayahi Selected topics in myasthenia gravis / |
author_facet |
Ali AL-Mayahi Al-Zwaini, Isam Jaber, Al-Mayahi, Ali, |
author_variant |
a a m aam |
author2 |
Al-Zwaini, Isam Jaber, Al-Mayahi, Ali, |
author2_variant |
i j a z ija ijaz a a m aam |
author2_role |
TeilnehmendeR TeilnehmendeR |
author_sort |
Ali AL-Mayahi |
title |
Selected topics in myasthenia gravis / |
title_full |
Selected topics in myasthenia gravis / edited by Isam Jaber Al-Zwaini, Ali Al-Mayahi. |
title_fullStr |
Selected topics in myasthenia gravis / edited by Isam Jaber Al-Zwaini, Ali Al-Mayahi. |
title_full_unstemmed |
Selected topics in myasthenia gravis / edited by Isam Jaber Al-Zwaini, Ali Al-Mayahi. |
title_auth |
Selected topics in myasthenia gravis / |
title_new |
Selected topics in myasthenia gravis / |
title_sort |
selected topics in myasthenia gravis / |
publisher |
IntechOpen IntechOpen, |
publishDate |
2019 |
physical |
1 online resource (94 pages) : illustrations |
isbn |
1-83880-831-0 1-83880-830-2 1-83880-829-9 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC935 |
callnumber-sort |
RC 3935 M8 S454 42019 |
illustrated |
Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.7442 |
dewey-sort |
3616.7442 |
dewey-raw |
616.7442 |
dewey-search |
616.7442 |
work_keys_str_mv |
AT alialmayahi selectedtopicsinmyastheniagravis AT alzwainiisamjaber selectedtopicsinmyastheniagravis AT almayahiali selectedtopicsinmyastheniagravis |
status_str |
n |
ids_txt_mv |
(CKB)4100000008878082 (NjHacI)994100000008878082 (oapen)https://directory.doabooks.org/handle/20.500.12854/59167 (EXLCZ)994100000008878082 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Selected topics in myasthenia gravis / |
author2_original_writing_str_mv |
noLinkedField noLinkedField |
_version_ |
1796652263375110144 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01130nam a2200325 i 4500</leader><controlfield tag="001">993541057304498</controlfield><controlfield tag="005">20221015173638.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221015s2019 enka ob 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-83880-831-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-83880-830-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000008878082</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994100000008878082</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/59167</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000008878082</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC935.M8</subfield><subfield code="b">.S454 2019</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.7442</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ali AL-Mayahi</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Selected topics in myasthenia gravis /</subfield><subfield code="c">edited by Isam Jaber Al-Zwaini, Ali Al-Mayahi.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2019</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London, England :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">[2019]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (94 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (InTech, viewed October 15, 2022).</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Myasthenia gravis is a rare potentially fatal chronic autoimmune disorder. Circulating autoantibodies directed against components of the neuromuscular junction of skeletal muscles, most commonly nicotinic acetylcholine receptor and associated protein in the postsynaptic membrane, block neuromuscular transmission resulting in muscle weakness. This muscle weakness typically worsens with continued activity, improves on rest, and is of variable severity ranging from mild ocular muscle weakness to severe generalized muscle weakness, involving the respiratory muscle with impending respiratory failure. The worldwide prevalence of myasthenia gravis is 100-200 per million population, affecting more than 700,000 people all over the world. The prevalence rate has increased since the 1950s due to improved diagnostic precision and decreased mortality rate.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Myasthenia gravis</subfield><subfield code="x">Diagnosis.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Neurology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mental and Behavioural Disorders and Diseases of the Nervous System</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Health Sciences</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-83880-829-9</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Al-Zwaini, Isam Jaber,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Al-Mayahi, Ali,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-02-22 20:19:18 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-08-10 22:08:00 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5351656850004498&Force_direct=true</subfield><subfield code="Z">5351656850004498</subfield><subfield code="b">Available</subfield><subfield code="8">5351656850004498</subfield></datafield></record></collection> |